StonvexLoading…
StonvexStonvexStonvexCore line items from HKHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $18.29M | $72.85M | $55.81M | $39.56M |
Operating Income | $-4.33M | $11.08M | $8.32M | $3.81M |
Net Income | $72.53M | $5.12M | $19.59M | $-10.49M |
EPS (Diluted) | $3.89 | $0.27 | $1.05 | $0.66 |
Total Assets | $2.23B | $2.00B | $2.18B | $2.06B |
Total Liabilities | $299.80M | $97.41M | $118.74M | $136.20M |
Cash & Equivalents | $36.74M | $36.88M | $37.72M | $38.85M |
Free Cash Flow OCF − CapEx | $-7.37M | $-43.38M | Not available | Not available |
Shares Outstanding | 18.64M | 18.64M | 18.64M | 18.64M |